1. Show article details.

    BRIEF-Rallybio Corp - Files For Mixed Shelf Offering Of Up To $300 Million - SEC Filing

    Reuters – 6:15 PM ET 08/08/2022

    Rallybio Corp (RLYB): * Rallybio Corp (RLYB) - FILES FOR MIXED SHELF OFFERING OF UP TO $300 MILLION - SEC FILING Further company coverage:

  2. Show article details.

    BRIEF-Rallybio Corp - Phase 1 Study Of Rlyb116 Ongoing Initial Single Dose Safety, PK, And PD Data Expected For 30 Mg Dose In 4Q 2022

    Reuters – 8:23 AM ET 08/08/2022

    Rallybio Corp (RLYB): * RALLYBIO REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS. * PHASE 1 STUDY OF RLYB116 ONGOING; INITIAL SINGLE DOSE SAFETY, PK, AND PD DATA EXPECTED FOR 30 MG DOSE IN 4Q 2022. * AS OF JUNE 30, 2022, CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES WERE $147.4 MILLION.

  3. Show article details.

    Rallybio Reports Second Quarter 2022 Financial Results

    Business Wire – 8:00 AM ET 08/08/2022

    -- Emerging data from Phase 1b study of RLYB212 shows rapid and complete elimination of transfused HPA-1a positive platelets -- -- Phase 1 study of RLYB116 ongoing; initial single dose safety, PK, and PD data expected for the 30 mg dose in the 4Q 2022 -- NEW HAVEN, Conn. “We continue to progress our pipeline toward planned upcoming milestones.

  4. Show article details.

    BRIEF-Rallybio Corp - On August 1, 2022 Board Increased Its Size From Nine Directors To Ten Directors

    Reuters – 9:55 AM ET 08/02/2022

    Rallybio Corp (RLYB): * Rallybio Corp (RLYB) - ON AUGUST 1, 2022 BOARD INCREASED ITS SIZE FROM NINE DIRECTORS TO TEN DIRECTORS Further company coverage:

  5. Show article details.

    Stocks That Hit 52-Week Lows On Tuesday

    Benzinga – 12:11 PM ET 06/14/2022

      On Tuesday, 951 companies hit new 52-week lows. On Tuesday, the following stocks set new 52-week lows: Be sure to stay with Benzinga for further updates and market-moving news.

  6. Show article details.

    Stocks That Hit 52-Week Lows On Monday

    Benzinga – 12:18 PM ET 06/13/2022

      During Monday's trading, 1214 companies set new 52-week lows. On Monday, the following stocks broke to new 52-week lows: Be sure to monitor Benzinga for the news traders need!

  7. Show article details.

    Stocks That Hit 52-Week Lows On Friday

    Benzinga – 11:45 AM ET 06/10/2022

      On Friday, 422 stocks made new 52-week lows. These stocks set new 52-week lows on Friday: Be sure to monitor Benzinga for the news traders need!

  8. Show article details.

    69 Biggest Movers From Friday

    Benzinga – 5:31 AM ET 06/06/2022

       

  9. Show article details.

    12 Health Care Stocks Moving In Friday's Intraday Session

    Benzinga – 2:10 PM ET 06/03/2022

      This article was generated by Benzinga's automated content engine and reviewed by an editor.

  10. Show article details.

    40 Stocks Moving In Friday's Mid-Day Session

    Benzinga – 12:07 PM ET 06/03/2022

     Gainers Turning Point Therapeutics, Inc. shares jumped 115.8% to $73.72 after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share.  Losers Bit Origin Limited shares dipped 41.9% to $0.5001 after the company priced a 9,803,922 share offering at $0.51 per share.  

  11. Show article details.

    BRIEF-Rallybio - Fryer Will Continue To Serve As Co's CFO Until A New CFO Has Been Appointed And Will Retire From Company Following A Transition Period

    Reuters – 8:35 AM ET 06/02/2022

    Rallybio Corp (RLYB): * RALLYBIO ANNOUNCES RETIREMENT OF JEFFREY FRYER, CPA, CHIEF FINANCIAL OFFICER. * RALLYBIO (RLYB) - FRYER WILL CONTINUE TO SERVE AS CO'S CFO UNTIL A NEW CFO HAS BEEN APPOINTED AND WILL RETIRE FROM COMPANY FOLLOWING A TRANSITION PERIOD. * HAS INITIATED AN EXTERNAL SEARCH TO IDENTIFY ITS NEXT CFO Source text for Eikon: Further company coverage:

  12. Show article details.

    Rallybio Announces Retirement of Jeffrey Fryer, CPA, Chief Financial Officer

    Business Wire – 8:30 AM ET 06/02/2022

    --Company initiates an external search for its next Chief Financial Officer-- Rallybio Corporation (RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today announced that Jeffrey Fryer, CPA, will retire from his position as Chief Financial Officer.

  13. Show article details.

    Rallybio to Present at Upcoming Investor Conferences in June

    Business Wire – 8:00 AM ET 06/01/2022

    Rallybio Corporation (RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today announced its participation in the following upcoming investor conferences: A live webcast of each presentation will be accessible through the Events and Presentations section of Rallybio’s website...

  14. Show article details.

    58 Biggest Movers From Yesterday

    Benzinga – 5:29 AM ET 05/24/2022

    58 Biggest Movers From Yesterday

  15. Show article details.

    Stocks That Hit 52-Week Lows On Monday

    Benzinga – 11:44 AM ET 03/28/2022

      On Monday, 147 stocks hit new 52-week lows. During Monday, the following stocks broke to new 52-week lows: Be sure to monitor Benzinga for the news traders need!

  16. Show article details.

    Stocks That Hit 52-Week Lows On Wednesday

    Benzinga – 11:47 AM ET 03/23/2022

      On Wednesday, 63 companies set new 52-week lows. On Wednesday, the following stocks hit new 52-week lows: Be sure to stay with Benzinga for further updates and market-moving news.

  17. Show article details.

    How Is The Market Feeling About Rallybio Corporation - Common Stock?

    Benzinga – 12:05 PM ET 03/21/2022

    Rallybio Corporation - Common Stock's short percent of float has fallen 14.21% since its last report. Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock.

  18. Show article details.

    Stocks That Hit 52-Week Lows On Thursday

    Benzinga – 12:39 PM ET 03/17/2022

      Thursday saw 34 companies set new 52-week lows. During Thursday, the following stocks broke to new 52-week lows: Be sure to monitor Benzinga for the news traders need!

Page:

Today's and Upcoming Events

  • Nov
    10

    RLYB to announce Q3 earnings (Unconfirmed)

Past Events (last 90 days)

  • Aug
    08

    RLYB announced Q2 earnings.

Data provided by Thomson Reuters © 2022

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.